BlackRock, Inc. 13D and 13G filings for West Pharmaceutical Services, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 5:23 pm Sale | 2023-12-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 7,778,203 10.500% | -370,421 (-4.55%) | Filing |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 8,148,624 11.000% | 54,336 (+0.67%) | Filing |
| 2022-01-26 8:18 pm Unchanged | 2021-12-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 8,094,288 10.900% | 0 (Unchanged) | Filing |
| 2022-01-25 11:15 am Purchase | 2021-12-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 8,094,288 10.900% | 626,479 (+8.39%) | Filing |
| 2021-04-09 6:02 pm Purchase | 2021-03-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 7,467,809 10.100% | 176,869 (+2.43%) | Filing |
| 2021-02-01 08:30 am Sale | 2020-12-31 | 13G | West Pharmaceutical Services, Inc. WST | BlackRock Inc. BLK | 7,290,940 9.900% | -867,980 (-10.64%) | Filing |